Latest filing published 18 Apr 2016 for Actinium Pharmaceuticals, Inc., €14k.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -24.1%Entry US$59.70 · Close at T+365 US$45.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kaushik J. Dave: trading record in brief
This profile gathers the share dealings of Kaushik J. Dave across 2 companies, led by Antares Pharma, Inc. and Actinium Pharmaceuticals, Inc. Between 9 September 2011 and 14 April 2016, the trades on record add up to 17 filings.
On the open market, the record shows 2 purchases worth €18k and 2 sales worth €184k. Netting one side against the other leaves €166k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 share grants and 2 option exercises. Since January 2016: 2 purchases and no sales on the market.
The newest entry dates from 18 April 2016: an open-market purchase of €14k, in Actinium Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kaushik J. Dave
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000 shares@ US$2.0280.1% of flowCommon StockSEC:0001213900-16-012634:0Canonical exit: 13 Jul 2016 (T+90)
- 2,000 shares@ US$2.0119.9% of flowCommon StockSEC:0001213900-16-012634:1Canonical exit: 13 Jul 2016 (T+90)
- 7,083 shares@ US$2.45Common stockSEC:0001213900-15-004135:0
- 27,501 shares@ US$2.45Common stockSEC:0001213900-15-004135:1
- 16,000 shares@ US$2.45Common stockSEC:0001213900-15-004135:2
- 68,000 shares@ US$2.45Common StockSEC:0001213900-15-004135:3
- 12,500 shares@ US$2.45Common stockSEC:0001213900-15-004135:4
- 25,000 shares@ US$2.45Common stockSEC:0001213900-15-004135:5
- 48,000 shares@ US$0.47Common StockSEC:0001181431-13-032916:0
- 48,000 shares@ US$4.0114Common StockSEC:0001181431-13-032916:1
- 29,461 sharesCommon StockSEC:0001181431-13-030732:0
- 29,461 sharesCommon StockSEC:0001181431-13-030732:1
- 12,000 shares@ US$0.47COMMON STOCKSEC:0001181431-13-026288:0
- 12,000 shares@ US$4.0201COMMON STOCKSEC:0001181431-13-026288:1
- 21,127 sharesCommon StockSEC:0001181431-12-040337:0
- 16,887 sharesCommon StockSEC:0001140361-12-007487:0
- 34,155 sharesCommon StockSEC:0001140361-11-045673:0
17 of 17 declarations
